Full text
PDF![1227](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f8/1645884/3ba73eb2b749/procrsmed00314-0047.png)
![1228](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f8/1645884/1f82440ebc5f/procrsmed00314-0048.png)
![1229](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f8/1645884/21223d5b79a9/procrsmed00314-0049.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BUCHTHAL F., SVENSMARK O., SCHILLER P. J. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960 Jun;2:624–630. doi: 10.1001/archneur.1960.03840120030004. [DOI] [PubMed] [Google Scholar]
- Bochner F., Hooper W. D., Tyrer J. H., Eadie M. J. Effect of dosage increments on blood phenytoin concentrations. J Neurol Neurosurg Psychiatry. 1972 Dec;35(6):873–876. doi: 10.1136/jnnp.35.6.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gibberd F. B., Dunne J. F., Handley A. J., Hazleman B. L. Supervision of epileptic patients taking phenytoin. Br Med J. 1970 Jan 17;1(5689):147–149. doi: 10.1136/bmj.1.5689.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huisman J. W., van Heycop ten Ham M. W., van Zijl C. H. Influence of ethylphenacemide on serum levels of other anti-epileptic drugs. Epilepsia. 1970 Jun;11(2):207–215. doi: 10.1111/j.1528-1157.1970.tb03882.x. [DOI] [PubMed] [Google Scholar]